osimertinib
astrazeneca,genprex
['tagrisso', 'acclaim-1', 'lung', 'osimertinib', 'lcsm,(-blcsm)']
clinical trial link quaratusugene ozeplasmid (reqorsa) and osimertinib in patients with advanced lung cancer who progressed on osimertinib (acclaim-1): #tagrisso #lcsm #asco2023 #lungcancer : 
Reading Markets since ‘95| Angel Strat @Genprex building gene therapies for Cancer & Diabetes $GNPX 🧬🚀| Cofounder https://t.co/ZiOhUvdGrL #lungcancer #diabetes #LCSM